A study of hematologic disorder in chronic obstructive pulmonary disease patients
- Conditions
- to study the relationship between hematologic disorders and COPD and to study various factors affecting hematologic disorders.chronic obstructive pulmonary disease, anemia, polycythemia, hemoglobin
- Registration Number
- TCTR20210504002
- Lead Sponsor
- grant from Faculty of Medicine, Srinakharinwirot University (Contract No 155/2563).
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 125
All chronic obstructive pulmonary disease patients visited to the COPD clinic, HRH Princess Maha Chakri Sirindhorn Medical Center Hospital between January 1, 2016, and December 31, 2019.
Patients with other lung diseases besides COPD such as asthma, infectious lung diseases, autoimmune diseases, cancer, metabolic diseases, hematologic diseases (leukemia, lymphoma, myeloproliferative disorder, pure red cell aplasia, thalassemia, bone marrow disease Heart failure Ischemic heart disease and osteoporosis
Patients who are treated with antibiotics and/or corticosteroids for a long time including any treatment that causes low immunity
Patients who lack follow-up
Patients with chronic renal disease stage 4 or 5
Patients without complete blood count results
Dementia
The variables used in this study were recorded including gender, age, body mass index(BMI), respiration rate, pulse rate, serum hemoglobin, hematocrit, leukocyte, eosinophil, mean corpuscular volume(MCV), MCHC, platelet, serum albumin, serum cholesterol, creatinine, glomerular filtration rate(GFR), peak expiratory flow rate(PEFR), post-bronchodilator FEV1, 6-minute walking distance, resting O2 saturation, frequency of exacerbations and frequency of admission.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method hematologic disorders data will be collected at the nearest time that COPD is diagnosed. CBC
- Secondary Outcome Measures
Name Time Method to study various factors affecting hematologic disorders. data will be collected at the nearest time that COPD is diagnosed. Complete blood count, biochemistry laboratory results, lung function test, 6-minute walking distance, frequency of exacerbations and admission were recorded